XML 35 R9.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Treasury Stock
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2021   113,014,528        
Beginning balance at Dec. 31, 2021 $ 6,021,460 $ 2,702,743 $ (6,401) $ 3,264,719 $ (54,861) $ 115,260
Beginning balance (in shares) at Dec. 31, 2021     (87,608)      
Increase (Decrease) in Shareholders' Equity            
Net Income 500,826     483,602   17,224
Other comprehensive income (loss) 23,426       23,426  
Dividends on common stock (387,975)     (387,975)    
Issuance of common stock (in shares)   232,661        
Issuance of common stock 21,996 $ 21,996        
Purchase of treasury stock (in shares) [1]     (77,152)      
Purchase of treasury stock [1] (5,152)   $ (5,152)      
Reissuance of treasury stock for stock-based compensation and other (in shares)     91,147      
Reissuance of treasury stock for stock-based compensation and other 6,548   $ 6,548      
Capital activities by noncontrolling interests (21,255)         (21,255)
Other 2 $ 1   1    
Ending balance (in shares) at Dec. 31, 2022   113,247,189        
Ending balance at Dec. 31, 2022 6,159,876 $ 2,724,740 $ (5,005) 3,360,347 (31,435) 111,229
Ending balance (in shares) at Dec. 31, 2022     (73,613)      
Increase (Decrease) in Shareholders' Equity            
Net Income 518,781     501,557   17,224
Other comprehensive income (loss) (1,709)       (1,709)  
Dividends on common stock (395,585)     (395,585)    
Issuance of common stock (in shares)   290,500        
Issuance of common stock 27,936 $ 27,936        
Purchase of treasury stock (in shares) [1]     (72,180)      
Purchase of treasury stock [1] (5,466)   $ (5,466)      
Reissuance of treasury stock for stock-based compensation and other (in shares)     32,521      
Reissuance of treasury stock for stock-based compensation and other 2,287   $ 2,287      
Capital activities by noncontrolling interests (21,255)         (21,255)
Other $ (3)   (1) (2)    
Ending balance (in shares) at Dec. 31, 2023 113,537,689 113,537,689        
Ending balance at Dec. 31, 2023 $ 6,284,862 $ 2,752,676 $ (8,185) 3,466,317 (33,144) 107,198
Ending balance (in shares) at Dec. 31, 2023 (113,272,000)   (113,272)      
Increase (Decrease) in Shareholders' Equity            
Net Income $ 626,030     608,806   17,224
Other comprehensive income (loss) 2,202       2,202  
Dividends on common stock (408,162)     (408,162)    
Issuance of common stock (in shares) [2]   5,606,093        
Issuance of common stock [2] 368,941 $ 368,941        
Purchase of treasury stock (in shares) [1]     (71,008)      
Purchase of treasury stock [1] (4,907)   $ (4,907)      
Reissuance of treasury stock for stock-based compensation and other (in shares)     137,312      
Reissuance of treasury stock for stock-based compensation and other 9,768   $ 9,768      
Capital activities by noncontrolling interests (21,255)         (21,255)
Other $ (1)   1 (2)    
Ending balance (in shares) at Dec. 31, 2024 119,143,782 119,143,782        
Ending balance at Dec. 31, 2024 $ 6,857,478 $ 3,121,617 $ (3,323) $ 3,666,959 $ (30,942) $ 103,167
Ending balance (in shares) at Dec. 31, 2024 (46,968)   (46,968)      
[1] Primarily represents shares of common stock withheld from certain stock awards for tax purposes.
[2] See Note 13 for information related to our equity forward sale agreements that were executed in February 2024 and November 2024. As of December 31, 2024, 5,377,115 shares of common stock have been issued as part of these agreements.